Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Zoetis Inc (ZTS) – Zoetis Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Zoetis (ZTS) trades at $74.22, down 1.67% amid bearish technical signals and recent earnings miss. The company reported Q1 2026 EPS of $1.53, missing the $1.60 estimate, and faces investor concerns following a 21.5% stock drop on May 7, 2026, after slashing full-year revenue guidance. Despite strong profitability metrics like a 28.03% net income margin and 67.75% ROE, valuation ratios such as a P/E of 12.17 appear attractive relative to historical levels, though near-term headwinds persist.
The outlook for ZTS is cautious due to competitive pressures and guidance cuts, but the stock's current valuation and analyst consensus price target of $124.67 suggest long-term potential. Key risks include generic competition impacting key drugs and weakened U.S. companion animal sales, requiring investor patience for a recovery.
Read full analysis

Key Stats

  • Market Cap
    $31.12B
  • Sector
    Health
  • 3M Drawdown
    -43.39%
  • Enterprise Value
    $38.41B
  • Dividend Yield
    2.86%
  • Typical Hold Time
    71 days
$74.15
52W Low: $74.15
18 May 2026
52W High: $170.3
03 Jun 2025

Zoetis Inc (ZTS) is currently valued at a market capitalization of $31.12B, with an enterprise value of $38.41B. Over the past 52 weeks, Zoetis Inc has traded between a low of $74.15 and a high of $170.3, highlighting its annual price range. Over the past three months, Zoetis Inc has recorded a drawdown of -43.39%, reflecting recent price volatility. Zoetis Inc offers a dividend yield of 2.86%, with the most recent dividend of $0.53 paid on 20 Apr 26. On average, investors hold Zoetis Inc for approximately 71 days, indicating typical investor behavior on the platform.

About Zoetis Inc

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.


Technical Indicators
|
|
|
Overall Summary
Bearish (16)Neutral (10)Bullish (1)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $31.12B
  • Sector
    Health
  • 3M Drawdown
    -43.39%
  • Enterprise Value
    $38.41B
  • Dividend Yield
    2.86%
  • Typical Hold Time
    71 days
$74.15
52W Low: $74.15
18 May 2026
52W High: $170.3
03 Jun 2025

Zoetis Inc (ZTS) is currently valued at a market capitalization of $31.12B, with an enterprise value of $38.41B. Over the past 52 weeks, Zoetis Inc has traded between a low of $74.15 and a high of $170.3, highlighting its annual price range. Over the past three months, Zoetis Inc has recorded a drawdown of -43.39%, reflecting recent price volatility. Zoetis Inc offers a dividend yield of 2.86%, with the most recent dividend of $0.53 paid on 20 Apr 26. On average, investors hold Zoetis Inc for approximately 71 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!